The International Society for Bipolar Disorders (ISBD) Task Force Report on Antidepressant Use in Bipolar Disorders


Creative Commons License

Pacchiarotti I., Bond D. J., Baldessarini R. J., Nolen W. A., Grunze H., Licht R. W., ...More

AMERICAN JOURNAL OF PSYCHIATRY, vol.170, no.11, pp.1249-1262, 2013 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Review
  • Volume: 170 Issue: 11
  • Publication Date: 2013
  • Doi Number: 10.1176/appi.ajp.2013.13020185
  • Journal Name: AMERICAN JOURNAL OF PSYCHIATRY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Social Sciences Citation Index (SSCI), Scopus
  • Page Numbers: pp.1249-1262
  • Dokuz Eylül University Affiliated: No

Abstract

Objective: The risk-benefit profile of antidepressant medications in bipolar disorder is controversial. When conclusive evidence is lacking, expert consensus can guide treatment decisions. The International Society for Bipolar Disorders (ISBD) convened a task force to seek consensus recommendations on the use of antidepressants in bipolar disorders.